n,n-dimethylarginine has been researched along with tamoxifen in 2 studies
Studies (n,n-dimethylarginine) | Trials (n,n-dimethylarginine) | Recent Studies (post-2010) (n,n-dimethylarginine) | Studies (tamoxifen) | Trials (tamoxifen) | Recent Studies (post-2010) (tamoxifen) |
---|---|---|---|---|---|
2,216 | 228 | 1,221 | 20,630 | 2,227 | 6,256 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Cartwright, JE; Holden, DP; Nussey, SS; Whitley, GS | 1 |
Al-Dhabi, NA; Arasu, MV; Arockiaraj, J; Arshad, A; Charles, S; Madhavan, T; Mala, K; Munusamy-Ramanujam, G; Saraswathi, NT; Singh, P | 1 |
2 other study(ies) available for n,n-dimethylarginine and tamoxifen
Article | Year |
---|---|
Estrogen stimulates dimethylarginine dimethylaminohydrolase activity and the metabolism of asymmetric dimethylarginine.
Topics: Amidohydrolases; Arginine; Cardiotonic Agents; Cell Line; Drug Implants; Endothelium, Vascular; Enzyme Activation; Estradiol; Female; Humans; Middle Aged; Postmenopause; Receptors, Estrogen; Tamoxifen | 2003 |
Pharmacologic downregulation of protein arginine methyltransferase1 expression by adenosine dialdehyde increases cell senescence in breast cancer.
Topics: Adenosine; Antineoplastic Combined Chemotherapy Protocols; Arginine; Betaine-Homocysteine S-Methyltransferase; Breast Neoplasms; Cell Cycle Checkpoints; Cell Proliferation; Cellular Senescence; Down-Regulation; Drug Synergism; Female; Gene Expression Regulation, Neoplastic; Humans; MCF-7 Cells; Methylation; Molecular Docking Simulation; Oxidative Stress; Phosphatidylethanolamine N-Methyltransferase; Protein Processing, Post-Translational; Protein-Arginine N-Methyltransferases; Repressor Proteins; Signal Transduction; Tamoxifen | 2021 |